DEFINITIVE PROXY STATEMENT

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

January 3, 2007

Period of Report

February 22, 2007

Accession Number

0001193125-07-000852

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →